Glucocorticoids Market was valued at US$ 4850 million in 2023 and is Anticipated to reach US$ 6690.5 Million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030

Glucocorticoids Market was valued at US$ 4850 million in 2023 and is Anticipated to reach US$ 6690.5 Million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030
Glucocorticoids Market Set to Surpass US$ 6690.5 Million by 2030, Propelled by Rising Incidence of Inflammatory and Autoimmune Diseases
The Glucocorticoids Market is expected to achieve a valuation of US$ 6690.5 million by 2030, showcasing a remarkable Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period from 2024 to 2030. This growth is driven by increasing prevalence of inflammatory and autoimmune diseases, coupled with advancements in drug development.

Synopsis

Glucocorticoids are given in relatively large doses for the treatment and prevention of cerebral edema in patients with brain tumors and in some patients with bacterial meningitis.

The global Glucocorticoids Market was valued at US$ 4850 million in 2023 and is anticipated to reach US$ 6690.5 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.

Topical corticosteroids are steroid medications that are applied directly to the skin to reduce inflammation and irritation. Topical corticosteroids come in many different forms, including creams, lotions, and gels. Topical steroids are used to treat skin conditions such as rashes, dermatitis, itching, eczema, and psoriasis, and this segment is expected to dominate the market owing to growing geriatric population across the world, increase in skin conditions, and prolonging duration. Increasing prevalence of skin-related disorders and rising incidence of rashes, dermatitis, itching, eczema, and psoriasis are boosting the growth of the corticosteroid market.

This report aims to provide a comprehensive presentation of the global market for Glucocorticoids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucocorticoids.

Report Scope

The Glucocorticoids market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glucocorticoids market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Glucocorticoids manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Request a Sample Copy or Connect for Further Details: https://www.themarketreports.com/report/ask-your-query/1737048

Market Segmentation

By Company

  • Pfizer
  • Novartis
  • Aspen
  • Euroapi
  • Sanofi
  • Avik Pharmaceutical Limited
  • Symbiotec
  • Cipla
  • Abbott Laboratories
  • Tianjin Tianyao Pharmaceuticals Co., Ltd.
  • Zhejiang Xianju Pharmaceutical Co.,Ltd
  • Shandong Xinhua Pharmaceutical Company Limited
  • Yangzi River Pharmaceutical Group

 

Segment by Type

  • Cortisone
  • Prednisone
  • Prednisolone
  • Methylprednisolone
  • Dexamethasone
  • Betamethasone
  • Hydrocortisone
  • Others

 

Segment by Application

  • Anti-inflammatory
  • Immunosuppressive
  • Vasoconstrictive

 

Consumption by Region

  •  North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

 

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Glucocorticoids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Glucocorticoids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Read More Related Research Reports:

Neuroendocrine Tumors (NETs) Treatment Market: https://www.themarketreports.com/report/global-neuroendocrine-tumors-nets-treatment-market-research-report

Cell Separation and Characterization in Solid Tumors Market: https://www.themarketreports.com/report/global-cell-separation-and-characterization-in-solid-tumors-market-research-report

Brain Tumor Treatment Market: https://www.themarketreports.com/report/global-brain-tumor-treatment-market-research-report

About US:

At ‘The Market Reports’, we are a trusted market research firm dedicated to empowering businesses with valuable insights and data to drive their success. We offer a wide range of comprehensive market research reports to meet the unique needs of each client. From market analysis and competitive intelligence to consumer behaviour and trend forecasting, we provide the critical information necessary to make informed decisions and stay ahead of the competition. Our goal is to empower our clients with the knowledge they need to drive growth, make strategic investments, and seize new opportunities.

Media Contact
Company Name: The Market Reports
Contact Person: Shirish Gupta
Email: Send Email
Phone: +16314071315
Address:SF-29, Sacred World, Wanawadi
City: Pune
State: Maharastra
Country: India
Website: https://www.themarketreports.com/report/global-glucocorticoids-market-research-report


Posted

in

by

Tags: